Lapinig, Dionesio S.

HRN: 10-78-45  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/22/2026
CEFTAZIDIME 1GM (VIAL)
06/22/2026
06/29/2026
IV
2g
Q8
CAPMR
Pending Pharmacy Acceptance 

 Indication:  Empiric    Type of Infection:  Pneumonia    Compliance to guidelines: